Public Theater may benefit from Donald-Trump-as-Julius-Caesar controversy

A backlash over two corporate sponsors pulling their funding of Shakespeare in the Park's Julius Caesar may be a boon for the nonprofit theater that produced it. Support for The Public Theater,... To view the full story, click the title link.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.